October 25, 2014 12:35 AM ET

Pharmaceuticals

Company Overview of Arisaph Pharmaceuticals, Inc.

Executive Profile

Christopher P. Kiritsy

Co-Founder, Chief Executive Officer, President and Director, Arisaph Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 4 different industries.

See Board Relationships
49--

Background

Mr. Christopher P. Kiritsy, also known as Chris, co-founded Arisaph Pharmaceuticals, Inc. in 1999 and has been its Chief Executive Officer & President since June 2005. Mr. Kiritsy served as Consultant of Kos Pharmaceuticals Inc. since May 23, 2005. He served as an Executive Vice President, Corporate Development and Chief Financial Officer of Kos Pharmaceuticals Inc., until May 20, 2005. He served as Senior Vice President of Kos Pharmaceuticals Inc. He played a key operating ...

Corporate Headquarters

100 High Street
Boston, Massachusetts 02110

United States

Phone: 617-986-4500
Fax: 617-986-4501

Board Members Memberships

1999-Present
Co-Founder, Chief Executive Officer, President and Director
2012-Present
Member of The Board of Directors
2014-Present
Director

Education

MBA
Boston University
BA
Bowdoin College

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Arisaph Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.